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Malaria is a one of the most dangerous disease in the 
world which is amongst the most prevalent communicable diseases 
worldwide [1]. Apart from being a major public health problem with 
high morbidity and mortality, it has also culminate other major socio-
economic problems causing global instability as well as poverty [2]. 
The disease especially in Africa and Asia continue to be a major 
threat to mankind [3]. Due to the complexity of the parasite life cycle 
and transmission of the disease, combating it has been a very difficult 
task to overcome. 
Malaria treatment using conventional (also called western 
or orthodox) medicine remains among the best methods for the 
disease management. Various forms of antimalarial treatments have 
been made available for the treatment of both simple and 
complicated malaria. Alongside the antimalarials used, antibiotics are 
also possible chemotherapy in cases of complicated malaria[4]. 
Though effective in treating malaria, orthodox medicine along the 
years has had some major drawbacks which have continued to 
question their supremacy in malaria management. So many, 
antimalarials such as chloroquine, amodiaquine, sulphadoxine-
pyrimethamine etc. used in the nineties are no longer effective in 
treating malaria [5]. Rather, malaria parasite has become resistant 
against these treatments and continue to develop new mechanisms 
for survivals [5]. Chemotherapy today has sort for combination 
therapy; combining the existing antimalarials with new compounds 
of artemisinin base. Yet, cases of resistance against artemisinin based 
combination therapy (ACT) have been observed along the Thailand-
Cambodian border in Asia with possibilities of spreading across the 
globe [6]. Also, apart from being ineffective, certain malaria 
treatment have also presented adverse effects and are toxic to the 
body [7]. This drives us to the question “is there no alternative to 
chemotherapy for malaria treatment?”. 
There are other types of medicine like naturopathy which 
have been used to manage malaria but their effectiveness still remain 
challenging. The most likely alternative to western medicine in recent 
time is herbal medicine. Herbal medicine which previously in the 
early 20th century was ignored in the global scenario of public health 
due to the rise of orthodox medicine is now gaining grounds in 
malaria treatment [8]. Artemisia annua plant used as folk Chinese 
herbal treatment for malaria which serves as the base for ACT is 
today widely used in various forms as herbal remedy for malaria [9]. 
This paper review the present state of malaria alongside the 
challenges of orthodox medicine in malaria management. It further 
emphasize on the contribution of herbal treatments in the 
management of malaria with possible suggestion for a better future 
for malaria management. 
 
2. Burden of Malaria 
Malaria situation is serious and getting worse around the 
world. Malaria threatens the lives of 40% of the world’s population 
and over 2200 million people are affected by the disease [3]. Each 
year, there are an estimated 300-500 million clinical cases and an 
estimated 660 000 deaths [3, 10]. Malaria is estimated to kill more 
than 1 million people annually, the majority of whom are young 
children [10]. Ninety per cent of malaria cases in the world occur in 
Sub-Sahara Africa [11]. Children under 5 years of age and pregnant 
women are the most affected by malaria [12] and it is one of the 
leading causes of death among young children. Together with 
pneumonia, diarrhoea, measles and malnutrition, malaria is 
responsible for over 70% of deaths in young children especially in 
developing countries [13]. Malaria during pregnancy causes severe 
maternal illness and anaemia, and is also associated with low birth 
weight among newborn infants, a leading risk factor for infant 
mortality.  
Malaria’s cost to human and social well-being is enormous. 
The mosquito-borne disease typically strikes its victims not once but 
repeatedly. As a result, workers’ output is diminished, and children 
miss school, often for periods of a week or more at a time. The 
economic loss from malaria was estimated at US$2 billion in Africa 
alone in 1997 [14]. Malaria is a major cause of poverty, and poverty 
exacerbates the malaria situation. Taken together, the effects of 
malaria on lives and livelihoods are devastating for economic 
progress in hard-hit countries. The World Health Organization and 
the World Bank rank malaria as the largest single component of the 
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disease burden in Africa, causing an annual loss of 35 million future 
life-years from disability and premature mortality [15]. In Africa, 
malaria is responsible for about 20-30% of hospital admissions and 
about 30-50% of outpatient consultations [15]. Malaria is also a 
major public health problem in parts of Asia, Latin America, the 
Middle East, Eastern Europe and the Pacific [16]. 
 
3. Malaria Parasite and Transmission  
Malaria is a disease caused by the eukaryotic parasite of 
the genus plasmodium [17]. Plasmodium is a parasite that feeds on 
blood during which it invades the red blood cells (RBC) in humans 
and destroy them causing shock and fever characterized with high 
temperatures. Malaria is caused by principally five plasmodium 
species namely; malariae, ovale, vivax, knowlesi and falciparum [1].  
Plasmodium falciparum is responsible for most malaria 
deaths, especially in Africa [18]. The infection can develop suddenly 
and produce several life-threatening complications. With prompt, 
effective treatment, however, it is almost always curable. Plasmodium 
vivax, the most geographically widespread of the species, produces 
less severe symptoms [19]. Relapses, however, can occur for up to 3 
years, and chronic disease is debilitating. Once common in temperate 
climates, P. vivax is now found mostly in the tropics, especially 
throughout Asia. Plasmodium malariae infections not only produce 
typical malaria symptoms but also can persist in the blood for very 
long periods, possibly decades, without ever producing symptoms 
[20]. A person with understanding malaria asymptomatic (no 
symptoms) P. malariae, however, can infect others, either through 
blood donation or mosquito bites. P. malariae has been wiped out 
from temperate climates, but it persists in Africa. Plasmodium ovale is 
rare, can cause relapses, and generally occurs in West Africa [21]. P. 
Knowlesi is the most recent species discovered in Asia in 2005 
responsible for malaria transmission from monkeys to humans [22]. 
Malaria parasite typically is transmitted to humans by 
mosquitoes belonging to the genus Anopheles. In rare cases, a person 
may contract malaria through contaminated blood, or a fetus may 
become infected by its mother during pregnancy. Because the 
malaria parasite is found in RBCs, malaria can also be transmitted 
through blood transfusion, organ transplant, or the shared use of 
needles or syringes contaminated with blood. Malaria also may be 
transmitted from a mother to her fetus before or during delivery 
(“congenital” malaria). Malaria parasite has a complex life cycle 
between humans and the mosquito vector anopheles [23].  
 
4. Conventional Medicine for Malaria treatment 
Effective malaria management must commence with 
laboratory diagnosis before administration of treatment. Malaria 
chemotherapy is complex and is dependent on certain factors. 
Treatments administered may vary depending on the plasmodium 
species present, the nature of the disease (simple or complicated 
malaria), human nature (children, adult, pregnant women), parasite 
geographical distribution and the intended therapeutic purpose 
(prophylaxis, Intermittent preventive treatment etc) as well as the 
drug susceptibility of the infecting parasite [24].  
The first antimalarial chemotherapy belongs to the class of 
amino quinines. This class contains treatments such as chloroquine, 
mefluoquine, amodaquine, primaquine etc. [25]. Another class of 
antimalarials is those of the antifolates such as sulfonamide and 
pyrimethamine. Lumefantrine, and halofantrine antimalarials belong 
to another class. Recently, artemisinin derivatives of the 
endoperoxidase class in the forms of arthemeter, artesunate, 
dihydroartemisinin are shown to be the most effective group of 
antimalarials which can exist as singles treatment or combined with 
other antimalarials as combination therapies [26]. Though 
chemotherapy has dominated malaria treatment, challenges such as 
drug resistance by the parasite has emerge. Some antimalarials are 
toxic to humans causing adverse effects.   
 
5. Antimalaria Drug Resistance 
Chloroquine which was the first antimalaria is no more 
recommended for treatment due to the occurrence of resistance in 
1959 [27]. The subsequent spread of chloroquine resistance set the 
scene for the discovery of new drugs. Antifolate combination, 
sulfonamide/pyrimethamine was the subsequent antimalarials used. 
After resistance to antifolates, there was increase deployment of 
quinine derivatives such as mefloquine, amodiaquine, and related 
lumefantrine, halofantrine antimalarial drugs. Resistance to 
antimalarials which originated in Asia has widely spread to South 
America and eastern parts of south Asia, and rapidly has gained 
ground in tropical Africa [28]. 
As a response to the antimalarial drug resistance situation, 
WHO recommended new treatment policies for P. falciparum malaria 
in all countries experiencing resistance to monotherapies, such as 
chloroquine, sulfadoxine/pyrimethamine, amodiaquine etc. to use 
combination therapies, preferably those containing artemisinin 
derivatives (Artemisinin-based Combination Therapy (ACT)) which 
are currently the most effective agents against multi-resistant 
malaria parasite strains. However, resistance due to P. falciparum 
against ACT has recently being observed along the Thialand-
Cambodian border in Asia [29].  
For simple malaria ACTs are recommended usually for oral 
administration route. In case where the illness is severe, intravenous 
or intramuscular route is used for antimalarials such as quinine or 
ACT which can be given in combination with some antibiotics such as 
clindamycin or doxycycline, tetracycline etc [4]. 
 
6. Antimalarials and Toxicity 
Most antimalarial drugs have shown to be toxic to the body 
developing adverse effects [30]. Chloroquine and amodiaquine have 
been shown to have similar toxic effect. Overdose of chloroquine can 
lead to cardiac toxicity. Large doses of amodiaquine have been 
reported to cause syncope, spasticity, convulsions and involuntary 
movements. Sulfadoxine shares the adverse effect profile of other 
sulfonamides, although allergic reactions can be severe because of its 
slow elimination. Nausea, vomiting, anorexia and diarrhoea may 
occur. Crystalluria causing lumbar pain, haematuria and oliguria is 
rare compared with more rapidly eliminated sulphonamides. 
Hypersensitivity reactions may affect different organ system. Larger 
doses of pyrimethamine may cause gastrointestinal symptoms such 
as atrophic glossitis, abdominal pain and vomiting, haematological 
effects including megaloblastic anaemia, leukopenia, 
thrombocytopenia and pancytopenia, and central nervous system 
effects such as headache and dizziness. Intramuscular artemether 
and artemotil are subject to neurotoxicity cause an unusual selective 
pattern of neuronal damage to certain brain stem nuclei. Primaquine 
cause plasma levels of the latter to increase 10-fold and exacerbated 
the already notorious toxicity of that drug and was withdrawn from 
the market by the US government [31,32].  
 
7. Herbal medicine versus Conventional Drugs 
Herbal medicine differs from a conventional 
pharmacotherapy on two main important aspects [33].  
Firstly, herbal medicine makes use of whole plant material 
containing several constituents and depends on synergic action for 
the effectiveness of the treatment. These plants constituents are of 
natural origin without any structural modification or chemical 
synthesis justifying the safety of herbal products. On the other hand, 
conventional medicine, sometimes certain plant constituents are 
fragmented and isolated to identify the principal active component 
which is chemical modified or synthesized as drugs.  
Secondly, Herbal medicine does not depend on the 
paradigm for specificity which conventional medicine is solely based 
on (only one -target monopharmacy). Rather, multiple action is the 
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case of herbal medicine as a result of the presence of a population of 
various phytochemical constituents (polypharmacy) without a 
specific target. This mixture of phytochemical is believed to reduce 
the toxicity of some plants by buffering effect [33, 34].  
 
8. Herbal medicine as malaria treatment 
According to the World Health Organization (WHO), the 
use of herbal remedies throughout the world exceeds that of the 
conventional drugs by two to three times [35, 36]. The use of plants 
for healing purposes predates human history and forms the origin of 
much modern medicine. Many conventional drugs had their origin 
from plant sources.  A few examples include aspirin (willow bark), 
digoxin (from foxglove), quinine (from cinchona bark), and morphine 
(from the opium poppy) [33].  
Some of our most important medicines come from plants, 
including two major antimalarial classes used to treat severe malaria; 
the cinchona alkaloids and artemisinins [36]. The cinchona alkaloids, 
like quinine, are extracted from the bark of trees originally grown in 
Peru and have a history that goes back more than 350 years [37]. 
Artemisinin is extracted from a herb, qinghao, which in being 
documented in traditional Chinese pharmacopoeia for treatment of 
fevers over two millennia, has a longer history of use. In 1967, the 
Government of the People’s Republic of China began a programme to 
identify antimalarial principles in plants used in traditional Chinese 
medicine [38]. By  1971, the Pharmaceutical Institute of the Academy 
of Traditional Chinese Medicine succeeded in showing that extracts 
of qinghao killed Plasmodium berghei invitro [39] and subsequently 
identified the active ingredient qinghaosu (“the active principle from 
qinghao”) in 1972 which is now called artemisinin [40]. Artemisinin 
is still obtained by extraction from qinghao (Artemisia annua -sweet 
Annie, sweet wormwood), a genus of plant that also gives us absinthe 
[40]. Once the structure of artemisinin was solved in 1977 [41], 
modifications were introduced to improve solubility in both oil and 
water. 
 
9. Herbal antimalarial Plants and Studies 
Today, several plants have been useD in the world as 
treatment for malaria and presented in different forms as teas bags, 
blisters, solutions, capsules, tablets etc. Over one hundred thirty nine 
medicinal plants have been reported for their use as antimalarials as 
stated by Satish and Kale [42]. Large numbers of plant species have 
been identified as antimalarial medicinal plants. A wide variety of 
plants belonging to several families have been identified through 
ethnobotanical and ethnopharmacological studies as antimalarial 
medicinal plants. A study by Willcox showed 1277 plant species from 
160 families listed that has been used to treat malaria [43]. 
Unfortunately five plants species used are among the endangered 
species thus cannot be further evaluated. Also, of these plants 47 
species are used on 2 continents and 11 species on all 3 tropical 
continents are used as antipyretics or antimalarials. In northeast 
India 65 medicinal plants from 38 different families have been 
reported to treat malaria, [44] while in South Viet Nam, of 49 plants 
identified as traditionally used for malaria, forty-six showed in vitro 
activity at 10 μg/mL [45]. Approximately 64% of the traditional 
malaria remedies in Kenya have been found in an in vitro model to 
exhibit anti-plasmodial activity [46].  
Among others, some of these medicinal plants have 
undergone clinical trials with good results. Notably, Cinchona spp. 
and A. annua, include the Ugandan formula “AM” in which 55% of 
patients had adequate clinical responses and 8% had clearance of 
parasites [47]. Terraplis interretis showed high rates of adequate 
clinical response to the point of clinical cure. [48]. Cryptolepsis 
sanguinolenta (Asclepiadaceae) has demonstrated activity similar to 
that of chloroquine; the extract cleared fever 12 hours faster, and 
cleared parasites within 24 hr [49]. 
Some plants have shown to be effective against certain 
resistant parasite strains. Bidens pilosa (Asteraceae) has shown 
activity against drug resistant P. falicparum parasites in vitro and in 
vivo in rodents [50, 51]. 
 
10. Conclusion 
Herbal medicine is widely used for the treatment of 
malaria in our world today. Several studies have confirmed the 
effectiveness of some herbal product in treating malaria in in vitro as 
well as in vivo studies using animals and in clinical trials. The 
increase used of herbal medicine over the conventional medicine in 
the treatment of malaria has been as a result of three main factors 
notably their safety, cost effectiveness and possible abilities of 
overcoming resistant parasite strains. However, though herbal 
medicine seem promising, its future and sustainability will only be 
achieved if the necessary standard practices are encouraged to 
improve on the efficacy and safety through clinical trials as well as 
building the capacity of herbal practitioners with professional ethics 
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